- Home
- CAH vs CCEP Comparison
CAH vs CCEP Comparison
Compare CAH & CCEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAH | CCEP |
|---|---|---|
| Founded | 1979 | 1986 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.7B | 43.1B |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CAH | CCEP |
|---|---|---|
| Price | $205.71 | $94.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $232.27 | $104.33 |
| AVG Volume (30 Days) | ★ 2.0M | 1.6M |
| Earning Date | 04-30-2026 | 02-17-2026 |
| Dividend Yield | 1.01% | ★ 2.48% |
| EPS Growth | ★ 86.96 | N/A |
| EPS | ★ 1.88 | N/A |
| Revenue | ★ $222,578,000,000.00 | N/A |
| Revenue This Year | $17.36 | $4.86 |
| Revenue Next Year | $9.06 | $3.79 |
| P/E Ratio | $107.17 | ★ $20.93 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $137.75 | $84.66 |
| 52 Week High | $233.60 | $110.90 |
Technical Indicators
Market Signals| Indicator | CAH | CCEP |
|---|---|---|
| Relative Strength Index (RSI) | 61.41 | 54.52 |
| Support Level | $205.33 | $89.92 |
| Resistance Level | $209.07 | $95.50 |
| Average True Range (ATR) | 3.54 | 2.11 |
| MACD | 1.19 | 0.22 |
| Stochastic Oscillator | 87.45 | 85.85 |
Price Performance
Historical ComparisonAbout CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
About CCEP Coca-Cola Europacific Partners plc
CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and Southeast Asia. In 2025, CCEP sold 3.9 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume.TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.